Mahdi Malekpour

Dr. Mahdi Malekpour

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2023 in Immunity, Inflammation and Disease
Verified
Journal Article
Open access
MMMahdi Malekpour
Mahdi Malekpour
SKShaghayegh Khanmohammadi
Shaghayegh Khanmohammadi
MMMohammad Javad Entezari Meybodi
Mohammad Javad Entezari Meybodi
DSDorsa Shekouh
Dorsa Shekouh
MRMohammad Reza Rahmanian
Mohammad Reza Rahmanian
NANegar Azarpira
Negar Azarpira
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) caused a pandemic with serious complications. After coronavirus disease 2019 (COVID‐19), several post‐acute COVID‐19 syndromes (PACSs) and long‐COVID sequels were reported. PACSs involve many organs, including the nervous, gustatory, and immune systems. One of the PACSs after SARS‐CoV‐2 infection and vaccination is Guillain‐Barré syndrome (GBS). The incidence rate of GBS after SARS‐CoV‐2 infection or vaccination is low. However, the high prevalence of COVID‐19 and severe complications of GBS, for example, autonomic dysfunction and respiratory failure, highlight the importance of post‐COVID‐19 GBS. It is while patients with simultaneous COVID‐19 and GBS seem to have higher admission rates to the intensive care unit, and demyelination is more aggressive in post‐COVID‐19 GBS patients. SARS‐CoV‐2 can trigger GBS via several pathways like direct neurotropism and neurovirulence, microvascular dysfunction and oxidative stress, immune system disruption, molecular mimicry, and autoantibody production. Although there are few molecular studies on the molecular and cellular mechanisms of GBS occurrence after SARS‐CoV‐2 infection and vaccination, we aimed to discuss the possible pathomechanism of post‐COVID‐19 GBS by gathering the most recent molecular evidence.

22 March 2023 in Epilepsia Open
Verified
Journal Article
Open access
MMMahdi Malekpour
Mahdi Malekpour
SSSeyed Reza Salarikia
Seyed Reza Salarikia
MKMohammad Kashkooli
Mohammad Kashkooli
AAAli Asadi-Pooya
Ali Asadi-Pooya
Objective: We aimed to explore the underlying pathomechanisms of the comorbidity between three common systemic autoimmune disorders (SADs) [i.e., insulin‐dependent diabetes mellitus (IDDM), systemic lupus erythematosus (SLE), and rheumatoid arthritis (RA)] and temporal lobe epilepsy (TLE), using bioinformatics tools. We hypothesized that there are shared genetic variations among these four conditions.Methods: Different databases (DisGeNET, Harmonizome, and Enrichr) were searched to find TLE‐associated genes with variants; their single nucleotide polymorphisms (SNPs) were gathered from the literature. We also did a separate literature search using PubMed with the following keywords for original articles: “TLE” or “Temporal lobe epilepsy” AND “genetic variation,” “single nucleotide polymorphism,” “SNP,” or “genetic polymorphism.” In the next step, the SNPs associated with TLE were searched in the LitVar database to find the shared gene variations with RA, SLE, and IDDM.Results: Ninety unique SNPs were identified to be associated with TLE. LitVar search identified two SNPs that were shared between TLE and all three SADs (i.e., IDDM, SLE, and RA). The first SNP was rs16944 on the Interleukin‐1β (IL‐1β) gene. The second genetic variation was ε4 variation of apolipoprotein E (APOE) gene.Significance: The shared genetic variations (i.e., rs16944 on the IL‐1β gene and ε4 variation of the APOE gene) may explain the underlying pathomechanisms of the comorbidity between three common SADs (i.e., IDDM, SLE, and RA) and TLE. Exploring such shared genetic variations may help find targeted therapies for patients with TLE, especially those with drug‐resistant seizures who also have comorbid SADs.

8 August 2025 in BMJ Case Reports
Verified
Journal Article
Open access
YZYuzhou Zhang
Yuzhou Zhang
MMMahdi Malekpour
Mahdi Malekpour
NANavid Al-Madani
Navid Al-Madani
KKKimia Kahrizi
Kimia Kahrizi
MZMarvam Zanganeh
Marvam Zanganeh
RSRichard J. H. Smith
Richard J. H. Smith
Syndromic hearing loss that results from contiguous gene deletions is uncommon.Three families with a novel syndrome characterised by deafness and infertility are described. Linkage was established by completing a genome-wide scan and candidate genes in the linked region were screened by direct sequencing. The deleted region is about 100 kb long and involves four genes (KIAA0377, CKMT1B, STRC and CATSPER2), each of which has a telomeric duplicate. This genomic architecture underlies the mechanism by which these deletions occur. CATSPER2 and STRC are expressed in the sperm and inner ear, respectively, consistent with the phenotype in persons homozygous for this deletion. A deletion of this region has been reported in one other family segregating male infertility and sensorineural deafness. We have identified three families segregating an autosomal recessive contiguous gene deletion syndrome characterised by deafness and sperm dysmotility. This new syndrome is caused by the deletion of contiguous genes at 15q15.3.

30 December 2023 in Epilepsy & Behavior
Verified
Journal Article
Closed access
AAAli Asadi-Pooya
Ali Asadi-Pooya
MMMahdi Malekpour
Mahdi Malekpour
ETEhsan Taherifard
Ehsan Taherifard
AMArashk Mallahzadeh
Arashk Mallahzadeh
MKMohsen Farjoud Kouhanjani
Mohsen Farjoud Kouhanjani

15 December 2024 in Iranian Journal of Psychiatry and Behavioral Sciences
Verified
Journal Article
Open access
PDF file
HJHassan Joulaei
Hassan Joulaei
ZFZohre Foroozanfar
Zohre Foroozanfar
MPMohammad Parhizkar
Mohammad Parhizkar
MBMaryam Bakhtiar
Maryam Bakhtiar
MMMahdi Malekpour
Mahdi Malekpour
Background: Depression, anxiety, and stress are prevalent among medical sciences students globally and contribute to suicidal ideation. Many risk factors are associated with the mental health problems of medical sciences students. Objectives: This study aimed to estimate the prevalence of depression, anxiety, stress, and suicidal ideation, as well as their associated factors, among medical, dental, and pharmacy students in the aftermath of the COVID-19 pandemic. Methods: In this cross-sectional study, we included 292 students. We collected background information and data on socioeconomic status (SES). We used the Depression, Anxiety, and Stress Scales-21 (DASS-21) and the Beck Scale for suicidal ideation (BSSI) to assess depression, anxiety, stress, and suicidal ideation. The data were analyzed using a linear regression model. Results: The prevalence of medium to high-risk suicidal thoughts among all students was 56.8%, with 6.5% of students reporting high-risk suicidal thoughts. The prevalence of mild to extremely severe depression, anxiety, and stress was 66.8%, 59.5%, and 52.1%, respectively. Factors significantly associated with the severity of suicidal thoughts included being single (β = -2.11), having a positive history of psychiatric illness (β = 2.64), having a positive history of chronic medical conditions (β = 4.23), and higher scores of depression (β = 1.97) and anxiety (β = 0.49). Additionally, a higher academic semester and greater interest in courses were significantly associated with lower scores of depression, anxiety, and stress. Conclusions: The findings of this study revealed a higher rate of depression, anxiety, stress, and suicidal ideation among medical sciences students compared to the global prevalence. This underscores the urgent need for targeted interventions to improve students’ mental health. More specifically, recognizing the risk factors for suicidality and promoting access to counseling services and mental health awareness programs can help prevent suicidal thoughts.

17 March 2024 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PHPardis Habibi
Pardis Habibi
KFKimia Falamarzi
Kimia Falamarzi
NENiloofar Dehdari Ebrahimi
Niloofar Dehdari Ebrahimi
MZMohammad Zarei
Mohammad Zarei
MMMahdi Malekpour
Mahdi Malekpour
NANegar Azarpira
Negar Azarpira
Growth differentiation factor 11 (GDF11), also known as bone morphogenetic protein 11 (BMP11), has been identified as a key player in various biological processes, including embryonic development, aging, metabolic disorders and cancers. GDF11 has also emerged as a critical component in liver development, injury and fibrosis. However, the effects of GDF11 on liver physiology and pathology have been a subject of debate among researchers due to conflicting reported outcomes. While some studies suggest that GDF11 has anti‐aging properties, others have documented its senescence‐inducing effects. Similarly, while GDF11 has been implicated in exacerbating liver injury, it has also been shown to have the potential to reduce liver fibrosis. In this narrative review, we present a comprehensive report of recent evidence elucidating the diverse roles of GDF11 in liver development, hepatic injury, regeneration and associated diseases such as non‐alcoholic fatty liver disease (NAFLD), non‐alcoholic steatohepatitis (NASH), liver fibrosis and hepatocellular carcinoma. We also explore the therapeutic potential of GDF11 in managing various liver pathologies.